XASX
IDX
Market cap553mUSD
Oct 09, Last price
2.15AUD
1D
0.94%
1Q
4.37%
Jan 2017
80.67%
IPO
14.97%
Name
Integral Diagnostics Ltd
Chart & performance
P/E
36.57
P/S
1.02
EPS
0.06
Div yield, %
4.23%
Shrs. gr., 5y
13.34%
Rev. gr., 5y
17.72%
Revenues
789m
+25.73%
Net income
22m
+369.36%
CFO
95m
+29.10%
Dividend
Aug 28, 20260.06 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patients across Australia and New Zealand. The company manages its service delivery through a network of 67 radiology clinics. Integral Diagnostics was incorporated in 2008 and maintains its primary corporate office in Melbourne, Australia.
Key people
Jason Martinez
Chief Executive Officer, Managing Director · since 2026
Craig White
Chief Financial Officer · since 2022
Nikki Valle
General Counsel · since 2025
Manish Mittal
Radiologist Executive Director · since 2025
John Merity
Company Secretary · since 2025
Independent Non-Executive Director and Chair Elect · since 2023
Non-Executive Independent Director · since 2022
Laura McBain
Non-Executive Independent Director · since 2024
Non-Executive Independent Director · since 2023
Kevin Shaw
Non-Executive Independent Director · since 2024
IPO date
Oct 21, 2015
Employees
2,010
Domiciled in
AU
Incorporated in
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||